ClearPoint Neuro, Inc.
CLPT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -3.8% | 8.6% | 9.2% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 63.2% | 60.3% | 60.5% | 61.3% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -59.5% | -55.4% | -68.7% | -66.1% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -66.5% | -63.3% | -71% | -69.3% |
| EPS Diluted | -0.21 | -0.21 | -0.22 | -0.2 |
| % Growth | 0% | 4.5% | -10% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |